|
PROFILE
Pro Pointer, Inc., through its wholly owned subsidiary Coenzyme-A Technologies, Inc., is an innovative company that has applied new technology to the formulation and manufacture of a series of proprietary products which address nutritional deficiencies that result from the stress of modern day living, chemical imbalances within the body, and the deleterious effects of aging. Coenzyme-A is the first nutraceutical product to combine nutritional components that can be successfully used by the body to support its manufacture and utilization of cellular Coenzyme-A (The Master Coenzyme). Coenzyme-A contains a specific set of substrates that are designed to assist the body in converting fats, carbohydrates and proteins into energy at the cellular level.
| Value Proposition |
 |
Conenzyme-A Technologies Inc. is an innovative company that has applied new technology to the formulation and manufacture of a series of proprietary products which address nutritional deficiencies that result from the stress of modern day living, chemical imbalances within the body, and the effects of aging.
Conenzyme-A Technologies is managed by a team of professionals with backgrounds that include the following expertise:
- Medical Professionals
- Biochemists & Nutrition Professionals
- Cellular Biologists
- Hair and Skin Specialists
- Clinical Nutrition Specialists
- Professional Trainers
- Marketing and Outside Sales Professionals
- Retail Health Food Sales Professionals
- Professional Consulations available by Appointment
Coenzyme-A Tech. Inc. is a science based company primarily engaged in the development of nutraceutial supplements and uniquely efficacious and patentable skin and hair care products to be available without prescriptions. These products are designed to make skin and hair look and feel younger on sustained basis by attacking the cellular causes of skin aging and decreased hair density.
These products will consist mainly of novel micronutrient ingredients uniquely targeted into the under layers of skin for maximum therapeutic benefit. Skin and Hair-Matrix compounds will deliver unique nutrient supplementation into the dermis, epidermis and hair follicle via its proprietary Active TransportTM delivery system.
Coenzyme-A Technologies, Inc., recently announced it is continuing the distribution negotiations with ERC Saglik Urunleri, a Mediterranean Company, and also Global Pharmaceuticals, a Middle Eastern and North African Company. Both of these companies are leading international wholesale pharmaceutical distributors for medical-optical devices, pharmaceutical equipment and nutraceutical products and have large customer bases in the Mediterranean region, North Africa and the Middle East territories. ERC Saglik Urunleri is currently serving many of the over 1,100 hospitals, 18,000 independent pharmacies and approximately 22,000 independent medical practices in their respective territories.
Verbal negotiations have indicated that an Opening Order by ERC Saglik Urunleri alone is estimated to be at 500,000 individual units of the "Pure Coenzyme-A" nutraceutical product development. This translates to approx. over $15,000,000.00 in sales alone from this pending business transaction. These two pending agreements could possibly bring the company's annual earnings from approx. $500,000.00 in 2009 to well over the $30,000,000.00 million mark during the course of 2010.
DISCLAIMER You are receiving this e-mail because you either opted into to our mailing list at smallcapvoice.com or at one of our Money Show exhibits. You may opt out at any time by clicking on the SafeUnsubscribe link at the bottom of this e-mail. Small Cap Voice SCV is an electronic publication, and is for informational purposes only. The stocks profiled by SCV are only company profiles and are not intended to be and should not be accepted by you as recommendations to buy or sell in these securities. These profiles are compiled from publicly available sources. Our sources include, but are not limited to, online research, company profiles, member suggestions, magazines, newspapers, analyst suggestions, broker recommendations, contact with the company, company rumors, press releases and other similar information sources. All profiles are based on information that is accessible by the public. Investing in stocks involves risk. SCV is not and does not hold itself out to be a registered broker or dealer or other licensed securities professional. You should consult a qualified, licensed financial advisor or stock broker before making any decisions to invest in the securities of any company that is described in these profiles. Small Cap Voice received $5,000 from a non-affiliate shareholder on 8/17/10 for 30 days of service. Link to full disclosure about compensation paid to SmallCapVoice.com, Inc. by companies featured on our website. |
